Associations of white matter hyperintensities with networks of gray matter blood flow and volume in midlife adults: A coronary artery risk development in young adults magnetic resonance imaging substudy.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
15 08 2022
Historique:
revised: 01 04 2022
received: 11 02 2022
accepted: 04 04 2022
pubmed: 17 4 2022
medline: 22 7 2022
entrez: 16 4 2022
Statut: ppublish

Résumé

White matter hyperintensities (WMHs) are emblematic of cerebral small vessel disease, yet effects on the brain have not been well characterized at midlife. Here, we investigated whether WMH volume is associated with brain network alterations in midlife adults. Two hundred and fifty-four participants from the Coronary Artery Risk Development in Young Adults study were selected and stratified by WMH burden into Lo-WMH (mean age = 50 ± 3.5 years) and Hi-WMH (mean age = 51 ± 3.7 years) groups of equal size. We constructed group-level covariance networks based on cerebral blood flow (CBF) and gray matter volume (GMV) maps across 74 gray matter regions. Through consensus clustering, we found that both CBF and GMV covariance networks partitioned into modules that were largely consistent between groups. Next, CBF and GMV covariance network topologies were compared between Lo- and Hi-WMH groups at global (clustering coefficient, characteristic path length, global efficiency) and regional (degree, betweenness centrality, local efficiency) levels. At the global level, there were no between-group differences in either CBF or GMV covariance networks. In contrast, we found between-group differences in the regional degree, betweenness centrality, and local efficiency of several brain regions in both CBF and GMV covariance networks. Overall, CBF and GMV covariance analyses provide evidence that WMH-related network alterations are present at midlife.

Identifiants

pubmed: 35429100
doi: 10.1002/hbm.25876
pmc: PMC9294299
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3680-3693

Subventions

Organisme : NIA NIH HHS
ID : R03 AG063213
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800007I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800006I
Pays : United States
Organisme : CIHR
ID : 165981
Pays : Canada

Informations de copyright

© 2022 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

J Neurosci. 2013 Feb 13;33(7):2889-99
pubmed: 23407947
Cerebrovasc Dis. 2009;28(2):177-84
pubmed: 19556771
Nat Rev Neurosci. 2009 Mar;10(3):186-98
pubmed: 19190637
Front Neurol. 2021 May 04;12:647848
pubmed: 34017302
Neuroimage. 2012 Jan 16;59(2):1239-48
pubmed: 21884805
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
J Cereb Blood Flow Metab. 2014 Jul;34(7):1091-5
pubmed: 24780899
Front Neurosci. 2016 Jun 30;10:308
pubmed: 27445677
IEEE Trans Med Imaging. 2002 Nov;21(11):1421-39
pubmed: 12575879
J Neurosci. 2010 Jul 14;30(28):9477-87
pubmed: 20631176
Alzheimers Dement. 2017 Jul;13(7):749-760
pubmed: 28137552
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
Sci Rep. 2018 May 10;8(1):7442
pubmed: 29748646
AJNR Am J Neuroradiol. 1999 Aug;20(7):1273-80
pubmed: 10472985
Transl Psychiatry. 2016 Nov 8;6(11):e947
pubmed: 27824356
JAMA. 2019 Aug 13;322(6):524-534
pubmed: 31408137
Cerebrovasc Dis. 2009;28(3):227-42
pubmed: 19571536
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
Biol Psychiatry. 2013 Nov 15;74(10):777-85
pubmed: 23601854
Hum Brain Mapp. 2017 Apr;38(4):1751-1766
pubmed: 27935154
Hum Brain Mapp. 2016 Jul;37(7):2446-54
pubmed: 27004840
Ann Neurol. 1999 Dec;46(6):827-33
pubmed: 10589534
Circulation. 2020 Mar 3;141(9):712-724
pubmed: 31747780
Neuroimage. 2018 Apr 15;170:5-30
pubmed: 28412442
AJNR Am J Neuroradiol. 2019 Aug;40(8):1291-1298
pubmed: 31345946
Ann Neurol. 2015 Feb;77(2):251-61
pubmed: 25428654
J Neurosci. 2016 Nov 30;36(48):12083-12094
pubmed: 27903719
Diabetes Care. 2011 Jan;34 Suppl 1:S62-9
pubmed: 21193628
Nat Rev Neurosci. 2013 May;14(5):322-36
pubmed: 23531697
Hum Brain Mapp. 2013 Dec;34(12):3411-25
pubmed: 22927119
J Neurol. 2006 Jul;253(7):919-27
pubmed: 16502217
Cereb Cortex. 2011 Sep;21(9):2147-57
pubmed: 21330467
Int J Aging Hum Dev. 1980;11(3):193-209
pubmed: 7203662
Neuroimage. 2012 Jul 16;61(4):1129-42
pubmed: 22440648
Neurology. 2019 Jun 11;92(24):1146-1156
pubmed: 31142635
Front Aging Neurosci. 2019 Dec 10;11:347
pubmed: 31920627
Neuroimage. 2013 Jan 1;64:173-84
pubmed: 22975159
Sci Rep. 2020 Jun 8;10(1):9210
pubmed: 32514044
Stroke. 2015 Feb;46(2):425-32
pubmed: 25572411
Hum Brain Mapp. 2009 Apr;30(4):1155-67
pubmed: 18465744
Front Neurol. 2018 Feb 26;9:94
pubmed: 29535678
Brain Commun. 2019;1(1):fcz041
pubmed: 31894208
Brain. 2016 Apr;139(Pt 4):1164-79
pubmed: 26912649
Magn Reson Imaging. 2012 Dec;30(10):1409-15
pubmed: 22789842
Brain Struct Funct. 2017 Nov;222(8):3833-3845
pubmed: 28474183
Neurology. 2001 Jun 12;56(11):1539-45
pubmed: 11402112
Neurobiol Aging. 2020 Feb;86:64-74
pubmed: 31813626
Neuroimage Clin. 2018 Feb 08;18:425-432
pubmed: 29541576
Neuroimage. 2010 Apr 15;50(3):970-83
pubmed: 20035887
Front Aging Neurosci. 2015 Jul 08;7:131
pubmed: 26217223
J Comput Assist Tomogr. 1998 Sep-Oct;22(5):827-37
pubmed: 9754125
Ann Neurol. 2005 Oct;58(4):610-6
pubmed: 16178017
J Cereb Blood Flow Metab. 2016 Jul;36(7):1244-56
pubmed: 27142868
Hum Brain Mapp. 2016 Jan;37(1):300-10
pubmed: 26466741
Am J Psychiatry. 1991 May;148(5):617-20
pubmed: 2018163
Nat Rev Neurol. 2018 Jul;14(7):387-398
pubmed: 29802354
Neurology. 2008 Mar 18;70(12):935-42
pubmed: 18347315
Brain. 2011 Jan;134(Pt 1):73-83
pubmed: 21156660
J Cereb Blood Flow Metab. 2021 Aug;41(8):1988-1999
pubmed: 33487070
Lancet Neurol. 2019 Jul;18(7):684-696
pubmed: 31097385
Front Neurosci. 2016 Sep 01;10:394
pubmed: 27635121
Hum Brain Mapp. 2022 Aug 15;43(12):3680-3693
pubmed: 35429100
Sci Rep. 2012;2:336
pubmed: 22468223
Hum Brain Mapp. 2019 Aug 15;40(12):3647-3656
pubmed: 31115127
Hum Brain Mapp. 2021 Apr 1;42(5):1406-1415
pubmed: 33289924
Neurology. 2014 Jul 22;83(4):304-11
pubmed: 24951477
PLoS One. 2015 Mar 26;10(3):e0122138
pubmed: 25812012
Hum Brain Mapp. 2020 Apr 1;41(5):1167-1180
pubmed: 31746083
Neurology. 2004 Jul 27;63(2):246-53
pubmed: 15277616

Auteurs

William S H Kim (WSH)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Nicholas J Luciw (NJ)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Sarah Atwi (S)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Zahra Shirzadi (Z)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Sudipto Dolui (S)

Center for Functional Neuroimaging, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

John A Detre (JA)

Center for Functional Neuroimaging, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Ilya M Nasrallah (IM)

Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Walter Swardfager (W)

Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Canadian Partnership for Stroke Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada.
Dr. Sandra Black Centre for Brain Resilience & Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Robert Nick Bryan (RN)

Department of Diagnostic Medicine, University of Texas, Austin, Texas, USA.

Lenore J Launer (LJ)

Laboratory of Epidemiology and Population Science, National Institute on Aging, Bethesda, Maryland, USA.

Bradley J MacIntosh (BJ)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Canadian Partnership for Stroke Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Dr. Sandra Black Centre for Brain Resilience & Recovery, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH